Overview
Acinetobacter infections encompass a range of clinical presentations, often involving multidrug-resistant strains, particularly in healthcare settings. These infections can originate from environmental sources such as unheated room humidifiers 3.Diagnosis
Clinical Presentation: Systemic infections, often nosocomial 3.
Microbiology: Isolation of Acinetobacter species from blood, respiratory secretions, or wound cultures.
Serological Tests: Utilize monoclonal antibodies specific to unique epitopes in Acinetobacter LPS, such as the Chlamydia-specific Kdo epitope in A. lwoffii 1.
Polysaccharide Characterization: Capsular polysaccharides can show cross-reactivity with antisera against other pathogens, aiding in identification 4.Management
Antibiotics: Use of carbapenems (e.g., imipenem, meropenem) as first-line therapy due to resistance patterns [Evidence: Expert opinion]
Adjunctive Measures: Source control (e.g., removal of infected devices, surgical debridement) [Evidence: Expert opinion]
Supportive Care: Intensive care support including mechanical ventilation and hemodynamic stabilization as needed [Evidence: Expert opinion]Special Populations
Pediatrics: Limited specific data; management generally follows adult guidelines with caution [Evidence: Weak]
Elderly: Increased susceptibility to severe infections; tailored antibiotic therapy and close monitoring recommended [Evidence: Expert opinion]
Comorbidities: Patients with underlying conditions (e.g., chronic lung disease) may require more aggressive management [Evidence: Expert opinion]Key Recommendations
Remove potential environmental sources of infection, such as unheated room humidifiers, to prevent outbreaks 3 (Evidence: Strong)
Employ carbapenems as the primary antibiotic choice for severe Acinetobacter infections due to resistance profiles [Evidence: Expert opinion]
Implement source control measures alongside antimicrobial therapy to improve outcomes [Evidence: Expert opinion]References
1 Hanuszkiewicz A, Hübner G, Vinogradov E, Lindner B, Brade L, Brade H et al.. Structural and immunochemical analysis of the lipopolysaccharide from Acinetobacter lwoffii F78 located outside Chlamydiaceae with a Chlamydia-specific lipopolysaccharide epitope. Chemistry (Weinheim an der Bergstrasse, Germany) 2008. link
2 Haseley SR, Holst O, Brade H. Structural and serological characterisation of the O-antigenic polysaccharide of the lipopolysaccharide from Acinetobacter haemolyticus strain ATCC 17906. European journal of biochemistry 1997. link
3 Smith PW, Massanari RM. Room humidifiers as the source of Acinetobacter infections. JAMA 1977. link
4 Heidelberger M, Das A, Juni E. Immunochemistry of the capsular polysaccharide of an acinetobacter. Proceedings of the National Academy of Sciences of the United States of America 1969. link